{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:32:18Z","timestamp":1786984338135,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T00:00:00Z","timestamp":1645833600000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.annder.2020.08.052","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T19:27:03Z","timestamp":1611084423000},"page":"6-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Lupus erythematosus: Significance of dermatologic findings"],"prefix":"10.1016","volume":"148","author":[{"given":"C.","family":"Lenormand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lipsker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2020.08.052_bib0270","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.annder.2020.08.052_bib0275","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12016-017-8627-2","article-title":"The cutaneous spectrum of lupus erythematosus","volume":"53","author":"Ribeiro","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.annder.2020.08.052_bib0280","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0285","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/0961203310370044","article-title":"The need to revisit the nosology of cutaneous lupus erythematosus: the current terminology and morphologic classification of cutaneous LE: difficult, incomplete and not always applicable","volume":"19","author":"Lipsker","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.annder.2020.08.052_bib0290","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000091246","article-title":"The importance of thrombosis in patients with lupus erythematosus","volume":"212","author":"Lipsker","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2020.08.052_bib0295","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000113940","article-title":"Neutrophilic cutaneous lupus erythematosus. At the edge between innate and acquired immunity?","volume":"216","author":"Lipsker","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2020.08.052_bib0300","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1097\/MD.0000000000000351","article-title":"Lupus erythematosus and neutrophilic urticarial dermatosis: a retrospective study of 7 patients","volume":"93","author":"Gusdorf","year":"2014","journal-title":"Medicine"},{"key":"10.1016\/j.annder.2020.08.052_bib0305","series-title":"Dubois\u2019 lupus erythematosus","first-page":"3","article-title":"Historical background of discoid and systemic lupus erythematosus","author":"Talbott","year":"1993"},{"key":"10.1016\/j.annder.2020.08.052_bib0310","first-page":"297","article-title":"Lupus \u00e9ryth\u00e9mateux (\u00e9ryth\u00e8me centrifuge)","volume":"3","author":"Cazenave","year":"1850","journal-title":"Ann Malad Peau Syph"},{"key":"10.1016\/j.annder.2020.08.052_bib0315","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF01921090","article-title":"Neue Beitr\u00e4ge zur Kenntnis des Lupus erythematosus","volume":"4","author":"Kaposi","year":"1872","journal-title":"Arch Derm Syphilol"},{"key":"10.1016\/j.annder.2020.08.052_bib0320","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2007.09.039","article-title":"Comparison of histopathologic-clinical characteristics of Jessner's lymphocytic infiltration of the skin and lupus erythematosus tumidus: multicentre study of 46 cases","volume":"58","author":"R\u00e9my-Leroux","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0325","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000092832","article-title":"Could Jessner's lymphocytic infiltrate of the skin be a dermal variant of lupus erythematosus? An analysis of 210 cases","volume":"213","author":"Lipsker","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2020.08.052_bib0330","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000092282","article-title":"Classification of specific cutaneous manifestations in patients with lupus erythematosus: a time for change? The concept of dermal lupus erythematosus","volume":"212","author":"Lipsker","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2020.08.052_bib0335","doi-asserted-by":"crossref","first-page":"e2102","DOI":"10.1097\/MD.0000000000002102","article-title":"Blisters and loss of epidermis in patients with lupus erythematosus: a clinicopathological study of 22 patients","volume":"94","author":"Merklen-Djafri","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.annder.2020.08.052_bib0340","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.autrev.2004.10.003","article-title":"Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings","volume":"4","author":"Sontheimer","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.annder.2020.08.052_bib0345","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2133.2012.10969.x","article-title":"Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden","volume":"167","author":"Gr\u00f6nhagen","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0350","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archdermatol.2009.21","article-title":"Incidence of cutaneous lupus erythematosus, 1965\u20132005: a population-based study","volume":"145","author":"Durosaro","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0355","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1365-2133.2011.10272.x","article-title":"Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden","volume":"164","author":"Gr\u00f6nhagen","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0360","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2133.2011.10610.x","article-title":"Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus","volume":"166","author":"Chong","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0365","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/ced.14014","article-title":"Time to progression from discoid lupus erythematosus to systemic lupus erythematosus: a retrospective cohort study","volume":"45","author":"Elman","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0370","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2133.2004.06308.x","article-title":"The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; a focus on combined C2\/C4 deficiency","volume":"152","author":"Boeckler","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0375","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1067\/mjd.2001.117861","article-title":"A histologic and immunohistochemical study of chilblains","volume":"45","author":"Cribier","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0380","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00005792-200105000-00004","article-title":"Clinical and histopathologic features and immunologic variables in patients with severe chilblains. A study of the relationship to lupus erythematosus","volume":"80","author":"Viguier","year":"2001","journal-title":"Medicine"},{"key":"10.1016\/j.annder.2020.08.052_bib0385","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.0303-6987.2005.00351.x","article-title":"Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological, and molecular analysis of nine cases","volume":"32","author":"Massone","year":"2005","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.annder.2020.08.052_bib0390","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.revmed.2009.10.434","article-title":"Syndrome de Barraquer\u2013Simons au cours d\u2019un lupus \u00e9ryth\u00e9mateux syst\u00e9mique","volume":"31","author":"Ben Ghorbel","year":"2010","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.annder.2020.08.052_bib0395","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/annrheumdis-2018-214037","article-title":"Efficacy of JAK1\/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency","volume":"78","author":"Briand","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2020.08.052_bib0400","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/annrheumdis-2016-209841","article-title":"Familial chilblain lupus due to a gain-of-function mutation in STING","volume":"76","author":"K\u00f6nig","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2020.08.052_bib0405","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00393-019-0633-8","article-title":"State of the art: systemischer Lupus erythematodes [State of the art: systemic lupus erythematosus]","volume":"78","author":"Mucke","year":"2019","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0410","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2020.08.052_bib0415","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41584-018-0133-2","article-title":"New therapeutic strategies in systemic lupus erythematosus management","volume":"15","author":"Gatto","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0420","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archdermatol.2009.199","article-title":"Association of cigarette smoking but not alcohol consumption with cutaneous lupus erythematosus","volume":"145","author":"Boeckler","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0425","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1080\/21645515.2018.1469592","article-title":"The effect of history of abnormal pap smear or preceding HPV infection on the humoral immune response to quadrivalent human papilloma virus (qHPV) vaccine in women with systemic lupus erythematosus","volume":"14","author":"Dhar","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.annder.2020.08.052_bib0430","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/j.vaccine.2018.04.056","article-title":"Long-term immunogenicity of a quadrivalent human papillomavirus vaccine in systemic lupus erythematosus","volume":"36","author":"Mok","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.annder.2020.08.052_bib0435","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.vaccine.2017.04.001","article-title":"The safety and immunogenicity of Quadrivalent HPV (qHPV) vaccine in systemic lupus erythematosus","volume":"35","author":"Dhar","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.annder.2020.08.052_bib0440","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2020.08.052_bib0445","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0450","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jaad.2019.07.027","article-title":"An update on the use of hydroxychloroquine in cutaneous lupus erythematosus: a systematic review","volume":"82","author":"Shipman","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0455","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/bjd.15312","article-title":"Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis","volume":"177","author":"Chasset","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0460","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jaad.2015.09.064","article-title":"The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): an open-label prospective pilot study","volume":"74","author":"Chasset","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0465","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000246710","article-title":"Chloroquine\u2013quinacrine association in resistant cutaneous lupus","volume":"190","author":"Lipsker","year":"1995","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2020.08.052_bib0470","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaad.2017.08.045","article-title":"Changing antimalarial agents after inefficacy or intolerance in patients with cutaneous lupus erythematosus: a multicentre observational study","volume":"78","author":"Chasset","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0475","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jaad.2016.01.054","article-title":"Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients","volume":"74","author":"Fennira","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0480","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s40265-019-01151-8","article-title":"Current concepts and future approaches in the treatment of cutaneous lupus erythematosus: a comprehensive review","volume":"79","author":"Chasset","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.annder.2020.08.052_bib0485","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1177\/0961203317751065","article-title":"The cutaneous manifestations are significantly related to cerebrovascular in a Serbian cohort of patients with Hughes syndrome","volume":"27","author":"Stojanovich","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.annder.2020.08.052_bib0490","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2340\/00015555-3100","article-title":"Anetoderma and systemic lupus erythematosus: case report and literature review","volume":"99","author":"Iglesias-Puzas","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2020.08.052_bib0495","doi-asserted-by":"crossref","DOI":"10.5070\/D3233034289","article-title":"Anetoderma before development of antiphospholipid antibodies: delayed development and monitoring of antiphospholipid antibodies in an SLE patient presenting with anetoderma","volume":"23","author":"Xia","year":"2017","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.annder.2020.08.052_bib0500","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-4362.1990.tb03797.x","article-title":"Superficial migratory thrombophlebitis and the lupus anticoagulant","volume":"29","author":"Blum","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0505","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MD.0b013e3181943f5e","article-title":"Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature","volume":"88","author":"Kieffer","year":"2009","journal-title":"Medicine"},{"key":"10.1016\/j.annder.2020.08.052_bib0510","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/jdv.15984","article-title":"Neutrophilic urticarial dermatosis: an entity bridging monogenic and polygenic autoinflammatory disorders, and beyond","volume":"34","author":"Gusdorf","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2020.08.052_bib0515","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.annder.2018.06.010","article-title":"Neutrophilic urticarial dermatosis: a review","volume":"145","author":"Gusdorf","year":"2018","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2020.08.052_bib0520","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1600-0560.2006.00559.x","article-title":"Non-bullous neutrophilic dermatosis: an uncommon dermatologic manifestation in patients with lupus erythematosus","volume":"33","author":"Gleason","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.annder.2020.08.052_bib0525","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.jaad.2011.05.048","article-title":"Neutrophilic dermatosis revisited: an initial presentation of lupus?","volume":"67","author":"Pavlidakey","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2020.08.052_bib0530","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.semarthrit.2017.11.003","article-title":"Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 new cases and a literature review of 118 cases","volume":"48","author":"de Risi-Pugliese","year":"2018","journal-title":"Semin Arthritis Rheum"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963820311558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963820311558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:09:49Z","timestamp":1758971389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963820311558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0151963820311558"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2020.08.052","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lupus erythematosus: Significance of dermatologic findings","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2020.08.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}